Skip to main content
Natera, Inc. logo

Natera, Inc. — Investor Relations & Filings

Ticker · NTRA ISIN · US6323071042 LEI · 529900CQ3OZ0A0VYVU59 US Human health and social work activities
Open in API
Filings indexed 1,586 across all filing types
Latest filing 2017-11-08 Investor Presentation
Country US United States of America
Listing US NTRA

About Natera, Inc.

https://www.natera.com/

Natera, Inc. is a diagnostics company specializing in cell-free DNA (cfDNA) testing. The company develops and commercializes non-invasive tests focused on three primary areas: women's health, oncology, and organ health. In women's health, its products include the Panorama non-invasive prenatal test (NIPT) and the Horizon carrier screening test to assess genetic risks. The oncology portfolio features Signatera, a personalized molecular residual disease (MRD) test used to monitor cancer recurrence and treatment response. For organ health, its tests are designed to detect early signs of transplant rejection. Natera's technology aims to provide actionable information for personalized medical care, supported by extensive clinical validation through numerous peer-reviewed studies.

Recent filings

Filing Released Lang Actions
8-K Filing
Investor Presentation Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 8, 2017, reporting the results of operations and financial condition for the third quarter ended September 30, 2017. It references a press release and an investor presentation as exhibits. The document itself is relatively short (4188 characters) and primarily serves to announce the release of financial results and related materials rather than containing detailed financial statements or substantive financial data. According to the 'Menu vs Meal' rule, such a document is an announcement of a report rather than the report itself. The presence of an investor presentation as an exhibit also supports classification as an Investor Presentation. Therefore, the best classification is Investor Presentation (IP).
2017-11-08 English
4 Filing
Director's Dealing
2017-09-07 English
8-K Filing
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically details changes in executive severance benefits and employment agreements for certain officers, including the CEO, CTO, and CFO. This type of information pertains to changes in senior management arrangements and compensatory terms. There is no financial data or earnings information, nor is it an annual or quarterly report. The document is not a proxy statement or voting results announcement. The key section is Item 5.02, which relates to departure or appointment of directors or officers and their compensatory arrangements. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is sufficient and contains substantive detail about management changes, not just a brief announcement or certification, so it is not Regulatory Filings (RNS). Confidence is high given the clear match to the MANG category.
2017-08-21 English
8-K Filing
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement, specifically a credit agreement for a $100 million senior secured term loan facility. It details the terms of the loan, covenants, and related information. There are no financial statements or comprehensive financial data presented, nor is this an earnings release or annual/interim report. The document is primarily an announcement of a financing event and related contractual details. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is 6926 characters, which is sufficient for a detailed announcement but does not constitute a full financial report. Hence, the classification is CAP with high confidence.
2017-08-10 English
424B5 Filing
Capital/Financing Update Classification · 100% confidence The document is a prospectus supplement dated August 9, 2017, related to an offering of 300,000 shares of common stock by Natera, Inc. It references a registration statement filed pursuant to Rule 424(b)(5) and includes detailed information about the offering, risk factors, use of proceeds, and legal matters. The document is clearly a disclosure related to a capital raising event, specifically a stock offering. It is not an annual or quarterly report, earnings release, or any other type of financial report. The document is a formal offering prospectus supplement, which fits the category of Capital/Financing Update (CAP) as it provides updates on company fundraising and financing activities.
2017-08-10 English
10-Q Filing
Interim / Quarterly Report Q2 2017
2017-08-09 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.